Top compounds associated with response to C17orf49


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC -0.12 0.03
mRNA linifanib CTRPv2 pan-cancer AAC 0.079 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.075 0.03
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.071 0.03
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.072 0.03
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA PF-184 CTRPv2 pan-cancer AAC 0.071 0.04
Download CSV